Cerus Corporation to Present Clinical Data at the 35th Regional ISBT Congress in Milan

Reuters
05-29
<a href="https://laohu8.com/S/CERS">Cerus Corporation</a> to Present Clinical Data at the 35th Regional ISBT Congress in Milan

Cerus Corporation is set to showcase the latest clinical data for its INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan, from May 31 to June 4, 2025. The company will present data highlighting the broad applicability and benefits of the INTERCEPT system for platelets, plasma, cryoprecipitated fibrinogen complex, and red blood cells, including positive results from their Phase 3 ReCePI study.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cerus Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20250529887759) on May 29, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10